Searched for
ANTIFUNGAL DRUG DEVELOPMENT
How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- 'World near tipping point': Study warns about a deadly fungus that could kill millionsA concerning study reveals that the deadly fungus Aspergillus, known for causing severe lung infections, may spread across continents due t...
- What's Coccidioides (Valley Fever)? The 'Last of Us'-like deadly fungal superbug spreading globally and infecting even healthy peopleFungal infections are emerging as a global health crisis, with valley fever spreading rapidly due to climate change and wildfires. Drug res...
- Is there a new global health threat? Fungal superbugs spread panic with climate change expanding its reachA new global health threat is emerging as drug-resistant fungal infections such as Aspergillus fumigatus and Coccidioides are spreading, dr...
- 'Silent pandemic' danger: Fungal infections could be the next health crisis, scientists warnFungal infections are becoming increasingly resistant to medications, posing a significant global health threat. Researchers warn that thes...
- Untreatable fungal infections are now killing nearly 3.8 mn each year, WHO experts sound alarmDeadly Fungal Infection: The world faces a growing crisis in antifungal resistance, with fungal infections causing millions of deaths annua...
- Cipla partners with CSIR-CDRI to develop formulation for fungal keratitisDrug major Cipla on Thursday said it has tied up with CSIR-Central Drug Research Institute to jointly develop a novel ophthalmic formulatio...
- After US reports 2 highly contagious ringworm cases, CDC says ‘World is not ready’: ReportTwo women from the US have been infected with the drug-resistant strain of ringworm known as tinea. Experts say that the disease is highly ...
- Candida auris: All you need to know about the deadly fungus spreading across the U.SSome strains of Candida auris are categorized as superbugs due to their resistant to all three classes of antifungal medication used to tre...
- Crocodiles protected against fungal infections, could help human medicine
- Sustained rise in antimicrobial resistance in India: ICMR studyThis is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...
- Gufic Bio zooms 14%, hits 52-week high on drug approvalThe pharmaceutical firm received permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation (CDSCO)...
- Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...
- MSN Labs launches black fungus drug Posaconazole in IndiaMSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...
- Merck, Ranbaxy drug development deal called offUS drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...
- Merck ends pact with RanbaxySeparate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...
- Orchid enters into $100 mn licensing agreement with MerckDrug-maker Orchid Chemicals on Monday said it has entered into a USD 100-million (about Rs 470 crore) licensing agreement with Merck & Co f...
- Ranbaxy enters into pact with Merck for anti-infective drugsRanbaxy Laboratories has signed a strategic product development agreement with German pharma major Merck for drug discovery and clinical de...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
Load More
